(Q40765145)

23 September 2017

title

In vitro testing of the leukaemia monoclonal antibody WM-53 labeled with alpha and beta emitting radioisotopes (English)

1 reference

23 September 2017

Syed M Abbas Rizvi

1

1 reference

23 September 2017

A J Henniker

series ordinal

2

1 reference

23 September 2017

G Goozee

series ordinal

3

1 reference

23 September 2017

B J Allen

series ordinal

4

1 reference

23 September 2017

publication date

1 January 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

26

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

37-43

1 reference

Monoclonal antibodies in cancer detection and therapy

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Application of the dosimetric model described by Humm to target 131I monoclonal antibodies to leukaemic cells in the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Alpha- and beta-emitting radiolanthanides in targeted cancer therapy: the potential role of terbium-149

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Cell Survival Following Multiple-track Alpha Particle Irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

The specific inhibition of cellular clonogenic proliferation using 211At labelled lectins and antibodies--I

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

The in vitro radiobiology of astatine-211 decay

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6- methyldiethylenetriaminepentaacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Radioimmunotherapy with alpha-emitting nuclides

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Production of terbium-152 by heavy ion reactions and proton induced spallation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900096-0

7 January 2021

10.1016/S0145-2126(01)00096-0

Identifiers

DOI

1 reference

23 September 2017

1 reference